Mankind Pharma launches 45-day healthcare mission at Mahakumbh serving thousands of pilgrims with free health check-ups
Mankind Pharma, a renowned global pharmaceutical company, has set up a comprehensive healthcare camp at the Mahakumbh 2025 in Prayagraj, Uttar Pradesh, India, offering essential medical services and support to thousands of pilgrims. The initiative, which commenced on 13th January and will continue through to 26th January, representing a significant milestone in the company's commitment to community healthcare.
The camp, operational daily from 12 PM to 4 PM, offers free health check-ups, blood pressure monitoring, and first-aid facilities, addressing the diverse medical needs of pilgrims participating in the sacred gathering. Mankind Pharma is facilitating hundreds of free health check-ups for pilgrims coming at Mahakumbh every day through Mankind's medical team and Pathkind facilities.
About the initiative, Mr Sheetal Arora, Promotor and CEO of Mankind Pharma said, “Our commitment to community health drives us to support pilgrims during Mahakumbh. Through our health camp and product distributions, we aim to ensure that attendees have access to essential healthcare services and products, promoting their well-being throughout the event. By providing free medical consultations, distributing critical health supplements, and offering first-aid support, we strive to address the specific health challenges pilgrims face during this sacred gathering, ensuring their safety and comfort during such an important occasion.”
The initiative forms part of Mankind Pharma's broader Kind Care programme, reinforcing the company's dedication to enhancing community health and hygiene across India. The camp's comprehensive approach includes
Free medical consultations with qualified healthcare professionals
Distribution of essential medicines and healthcare products
Expert guidance on product usage and health maintenance
Specialised support for common pilgrim health concerns
Pathkind diagnostic services for detailed health assessments
Healthcare professionals at the camp report significant engagement from pilgrims, with services particularly focused on addressing the unique challenges faced during religious gatherings, including fatigue management and dietary health support.
About Mankind Pharma
Mankind Pharma (BSE: 543904 | NSE: MANKIND) is one of the largest pharmaceutical companies in India, which focuses on the domestic market with its Pan India presence. In a strategic move to strengthen its position in the Indian women's health and fertility drug market, Mankind Pharma recently acquired Bharat Serums and Vaccines. This acquisition enhances Mankind's portfolio and market reach in super speciality and high barriers to entry segments with BSVs highly capable product development capabilities. Mankind operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices. The company is a leading player in the domestic pharmaceuticals business present across acute and chronic therapeutic areas including anti-infectives, cardiovascular, gastrointestinal, antidiabetic, neuro/CNS, VMN and respiratory, among others with a strategy to increase chronic presence going ahead. The company has transferred its Over-the-Counter (OTC) business undertaking to its wholly owned subsidiary, Mankind Consumer Products Private Limited (MCPPL). Mankind Pharma’s consumer products portfolio includes several category-leading brands that include Manforce, HealthOK, Prega News, AcneStar, Unwanted and Gas-O-Fast across categories such as wellness, hygiene and personal care products.
The company has 30 manufacturing facilities in India manufacturing a wide range of dosage forms, including tablets, capsules, syrups, vials, ampoules, blow fill seal, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products. Mankind has a consistent track record of product innovation through 6 dedicated R&D facilities backed by more than 660 scientists.
Reach out to us at PR Desk
Read more on our Partner sites: Dais World | The Progress Catalyst
Get rewarded for your reading habits on the Dais World app!
